Xenon Pharmaceuticals Inc (XENE) — Capital Reinvestment Ratio
Xenon Pharmaceuticals Inc (XENE) has a Capital Reinvestment Ratio of 0.03x as of December 2019, meaning it reinvests 0% of its operating cash flow ($19.73 Million) in capital expenditures ($595.00K). See Xenon Pharmaceuticals Inc balance sheet quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Xenon Pharmaceuticals Inc Capital Reinvestment Ratio (2012–2014)
This chart tracks Xenon Pharmaceuticals Inc's Capital Reinvestment Ratio across 2 annual periods. Check XENE cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Xenon Pharmaceuticals Inc (2012–2014)
Year-by-year Capital Reinvestment Ratio for Xenon Pharmaceuticals Inc from 2012 to 2014. For live market cap and broader valuation context, see how much is Xenon Pharmaceuticals Inc worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2014 | 5.75x | $266.00K | $1.53 Million | ▲ +49702.1% |
| 2012 | 0.01x | $45.57 Million | $526.00K | — |